Navigation Links
Berg Launches First-Ever Stratified Medicine Clinical Trial To Investigate Cancer Metabolism Of Solid Tumors
Date:11/21/2013

y into underlying elements in the Warburg Hypothesis. The company has a deep pipeline of early-stage technologies in CNS diseases and metabolic diseases that complement its late-stage clinical trial activity in cancer and prevention of chemotoxicity. Armed with use of the discovery platform that translates biological output into viable therapeutics and a robust biomarker library, Berg is poised to realize its pursuit of a healthier tomorrow. For additional information, visit http://www.bergpharma.com/.

Media Contact:
Alisha Tischler
Ogilvy Public Relations
212-880-5218
alisha.tischler@ogilvy.com

Investor Contact:
Tom Smith
Ogilvy Public Relations
212-880-5269
tom.smith@ogilvy.com


'/>"/>
SOURCE Berg
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Linguamatics Launches Healthcare Product Suite to Turn Unstructured Electronic Health Record Data into Actionable Patient Insights
2. M&G Chemicals Launches Green Revolution in the Polyester Chain
3. TransCelerate BioPharma Inc. Launches Second Year Initiatives, Expands Membership and Achieves Milestones for Original Projects
4. Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer
5. Goldstone Scientific Launches, Offering an Easy Shopping Experience for Prizmatix Ultra High Power LED Systems
6. $100 Million Gift Launches Sanford Stem Cell Clinical Center
7. ISPE Launches New Expanded E-Learning Courses
8. Tute Genomics Launches at 2013 ASHG Conference
9. Trade Show Display Co. GLM Displays Launches New “Customer Spotlight” Campaign
10. How Companies Can Provide Extraordinary New B2B Products with Extraordinary Product Launches - A Sales Momentum White Paper
11. QB3 Launches New Biotech Incubator in San Francisco with 24 Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... According to a new market report published by ... was valued at USD 3,754.6 million in 2012 and is ... a CAGR of 5.9% from 2013 to 2019. , Nearly ... afflicted by bone and joint disorders, and this number is ... and will continue to increase the demand for orthobiologics. Other ...
(Date:8/29/2014)... 2014 Pittcon is pleased to announce ... Koichiro Matsuda, Horiba Scientific, have organized a session on ... JASIS , Asia’s largest analytical and scientific instruments ... Messe, Japan. , The four speakers in this ... Single Molecules to Single Cells” will present their use ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
(Date:8/29/2014)... 29, 2014 Local veterinarian, Dr. Keith ... are seeking candidates to participate in an investigational study ... The ultimate goal of this study is to determine ... one or two arthritically affected joints can help reduce ... Candidates for the current investigational study must be older ...
Breaking Biology Technology:Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... Serica Technologies, Inc., a,growth-stage medical device company, ... the first manufacturing run of its novel,biomaterial ... headquarters in,Medford, MA, includes 22,000 square feet ... as manufacturing and administrative,space. The facility is ...
... GenoTrim to play a role on the nation,s obesity ... genetics associated with hunger and ... Inc., a personalized,health and wellness company, announced the launch ... to achieve a healthy,weight through both standard weight reduction ...
... Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today ... will provide a corporate,presentation at the UBS Life ... 2007 at 4:00 p.m. Eastern time. A ... by visiting the,Investors section of the Jazz Pharmaceuticals ...
Cached Biology Technology:Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing 2Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing 3Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management 2Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management 3
(Date:8/29/2014)... phytoplankton, such as the prolific bloomer Emiliania huxleyi ... have discovered. The finding contradicts the common view that ... depend on scarce supplies of thiamine in the ocean ... think about the ocean," says CIFAR Senior Fellow ... paper with CIFAR fellows John Archibald ...
(Date:8/29/2014)... In a cell,s nucleus, chromosomal DNA is tightly ... amalgam biologists call chromatin. Until about two decades ... the mere packing material around which the glamorous ... developed a greater appreciation for how DNA/histone interactions ... multiple research institutions studying the sequence of the ...
(Date:8/29/2014)... Bend them, stretch them, twist them, fold them: modern ... extraordinary technological potential, whether as artificial skin or electronic ... use remains a challenge but a new way of ... could be a game-changer. , Previous success in ... on the use of precious gold and silver nanowires. ...
Breaking Biology News(10 mins):Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3Copper shines as flexible conductor 2
... a specific infrastructure call of the Seventh Framework Programme ... involving 30 partners from 17 countries, has received a ... industry scientists to the largest European ,biobanks,. ... EU biobanking programme BBMRI (Biobanking and Biomolecular Resources Research ...
... , April 10, 2013  Medbox, Inc. (OTC Markets: MDBX) ... 10 to become a fully reporting public company with ... of the many highlights of the filing is a ... holding affiliate, PVM International, Inc., has towards the company,s ...
... 10, 2013  Venetian Ballroom E – EyeLock Inc. ... the introduction of the new HBOX ® , its highly praised ... Stanley Security Solutions, Venetian Ballroom E during ISC ...  Capable of authenticating 50 people per minute, this high-throughput ...
Cached Biology News:8 M € from EU to enhance access by scientists to the largest European 'biobanks' 2Medbox Files Form 10 with SEC 2EyeLock Debuts Its New HBOX Iris Authentication System at ISC West 2EyeLock Debuts Its New HBOX Iris Authentication System at ISC West 3
... Pro is the industry standard microarray image ... of imaging and analysis tools, visualizations, automation ... Pro is included with every GenePix scanner, ... third-party scanners and all types of arrays. ...
A univariate (peak height or area) quantitative multi-component analysis package....
... Antigen sequence: H-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH 2 ... our corresponding peptide and ... 5 I-labelled peptide, ... (H-1470) and ([ 1 ...
... 1 is a dramatic breakthrough in accurate, small-volume ... 10nL resolution, the micro 1 has unique advantages ... the micro 1 never needs re-calibration as do ... programming on an LCD Display , Graphical Row ...
Biology Products: